- |||||||||| Trial completion, Enrollment change, Trial primary completion date: Metabolically Normal and Metabolically Abnormal Obesity (clinicaltrials.gov) - Apr 30, 2015
P=N/A, N=71, Completed, Enrolling by invitation --> Completed Recruiting --> Completed | N=40 --> 71 | Trial primary completion date: Aug 2015 --> Aug 2014
- |||||||||| Trial primary completion date: China Action on Spine and Hip Status (clinicaltrials.gov) - Apr 23, 2015
P=N/A, N=3000, Recruiting, Active, not recruiting --> Completed Trial primary completion date: Dec 2013 --> Dec 2015
- |||||||||| eplerenone / Generic mfg.
Trial primary completion date: Aldosterone Antagonism and Microvascular Function (clinicaltrials.gov) - Mar 11, 2015 P4, N=60, Recruiting, Recruiting --> Completed Trial primary completion date: Mar 2015 --> Feb 2016
- |||||||||| Enrollment closed, Trial primary completion date: CHANGE -it is About Life (clinicaltrials.gov) - Mar 5, 2015
P3, N=430, Active, not recruiting, Recruiting --> Active, not recruiting Not yet recruiting --> Active, not recruiting | Trial primary completion date: Aug 2016 --> May 2016
- |||||||||| Trial primary completion date: The Autonomic Nervous System and the Metabolic Syndrome (clinicaltrials.gov) - Feb 5, 2015
P=N/A, N=50, Active, not recruiting, Trial primary completion date: Dec 2012 --> Dec 2015 Trial primary completion date: Dec 2014 --> Dec 2015
|